2-Fluoro-4-(1-methyl-1h-pyrazol-4-yl)aniline, 95%, 250mg

1-(3-(TERT-BUTYL)-1-PHENYL-1H-PYRAZOL-5-YL)-3-(2-FLUORO-4-((3-OXO-3,4-DIHYDROPYRIDO[2,3-B]PYRAZIN-8-YL)OXY)PHENYL)UREA, 97%, 25mg

8-benzyl-4-(thiophene-2-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3-(2-Bromo-4,5-dimethoxyphenyl)propanenitrile, 95+%, 100g

Ácido pelargónico, mínimo 97 %, 50 ml, envase de vidrio

Inmunobloque ROTI®

N-[2-(tert-Butyldimethylsilyloxy)ethyl]methylamine, 95.0%, 10g

2,2'-(Adamantane-1,3-diyl)bis(ethan-1-ol), 95+%, 2g

tert-Butyl (3S,4R)-3-(hydroxymethyl)-4-(4-methoxyphenyl)pyrrolidine-1-carboxylate, 95.0%, 1g

S-Pyridin-2-yl 3-phenylpropanethioate, 97.0%, 250mg

4-(Trifluoromethylthio)benzylamine>97.0%(GC)(T)5g

(2-Chlorophenyl)diphenylphosphane, 98%, 1g

3,6-Dichloropyridazine-4-carboxylic acid, 98.0%, 500g